Detalhe da pesquisa
1.
Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy.
Ann Allergy Asthma Immunol
; 125(2): 196-201.e1, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32278075
2.
Quality of life in food allergic children: Results from 174 quality-of-life patient questionnaires.
Ann Allergy Asthma Immunol
; 124(4): 379-384, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31931105
3.
Emerging triggers of food protein-induced enterocolitis syndrome: Lessons from a pediatric cohort of 74 children in the United States.
Ann Allergy Asthma Immunol
; 122(4): 407-411, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30742916
4.
Anaphylaxis during Peanut Oral Immunotherapy: Looking beyond dose escalation.
Pediatr Allergy Immunol
; 33(12): e13888, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564873
5.
Insights into Microbiome and Metabolic Signatures of Children Undergoing Peanut Oral Immunotherapy.
Children (Basel)
; 9(8)2022 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010081
6.
Identification of goals and barriers to treatment from 92 consecutive consultations with families considering peanut oral immunotherapy.
Ther Adv Vaccines Immunother
; 7: 2515135519869763, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31489399
7.
Insights from 275 cases of childhood anaphylaxis in the United States.
J Allergy Clin Immunol Pract
; 7(5): 1696-1699.e2, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30580049